Cas 2679-37-0,3-(tert-butylamino)-1-phenylpropan-1-one

2679-37-0

Post Buying Request

Basic information

Product Name: 3-(tert-butylamino)-1-phenylpropan-1-one
Synonyms: 3-(tert-butylamino)-1-phenylpropan-1-one
CAS NO:2679-37-0
Molecular Formula:
Molecular Weight: 205.3
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(tert-butylamino)-1-phenylpropan-1-one(CAS DataBase Reference)
NIST Chemistry Reference: 3-(tert-butylamino)-1-phenylpropan-1-one(2679-37-0)
EPA Substance Registry System: 3-(tert-butylamino)-1-phenylpropan-1-one(2679-37-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 2679-37-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

2679-37-0 Suppliers

Recommended suppliers

2679-37-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2679-37-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,7 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2679-37:
(6*2)+(5*6)+(4*7)+(3*9)+(2*3)+(1*7)=110
110 % 10 = 0
So 2679-37-0 is a valid CAS Registry Number.

2679-37-0Upstream product

2679-37-0Downstream Products

1161353-66-7 methyl tert-butyl(3-oxo-3-phenylpropyl)carbamate

2679-37-0Relevant academic research and scientific papers

CYCLIC UREA INHIBITORS OF HB-HYDROXYSTEROID DEHYDROGENASE 1

-

Page/Page column 57, (2009/07/17)

This invention relates to novel compounds of the Formula (I), (Ia) and (Ib), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, j which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell Or the inhibition of the conversion of cortisone to Cortisol in a cell.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 2679-37-0